GET THE APP

..

Cancer Science & Therapy

ISSN: 1948-5956

Open Access

Hua Dong


The Research and Development Center of Precision Medicine, 3D Medicines Inc., Shanghai, P.R. China

Biography
The Research and Development Center of Precision Medicine, 3D Medicines Inc. Shanghai, P.R. China, Specialization in EGFR;  Erlotinib;  Osimertinib;  Lung  adenocarcinoma; Circulating tumor DNA assay, EGFR Primary T790M and L858R Double Mutation Confers Clinical Benefit to Erlotinib and Resistance to Osimertinib in One Lung Adenocarcinoma Patient: A Case Report

Relevant Topics

Google Scholar citation report
Citations: 3968

Cancer Science & Therapy received 3968 citations as per Google Scholar report

Cancer Science & Therapy peer review process verified at publons

Indexed In

arrow_upward arrow_upward